-
AASLD Interview | Professor Bernd Schnabl: Delving into the “Gut-Liver Axis,” Decoding the Role of Gut Microbiota in the Diagnosis and Treatment of Autoimmune Liver Diseases
The gut microbiome, a complex ecosystem within the human intestinal tract, has a broad impact on physiological functions. Gut microbiome imbalance has become one of the most critical environmental factors in the onset of chronic inflammatory diseases. The liver is one of the first identified targets of autoimmune attack. In recent years, with deeper research…
-
AASLD Interview丨Professor Jeffrey V. Lazarus: Clinical Management, Research Priorities, and Future Action Plans for MASLD
The 2023 American Association for the Study of Liver Diseases (AASLD 2023) recently concluded in Boston, USA. metabolic dysfunction-associated steatotic liver disease (MASLD) was a key topic at the conference. In the “Healthy Liver, Healthy Lives” session, experts discussed how to reverse the global MASLD trend and what actions to take to address MASLD management…
-
CCHIO International Vision丨Dr. Dorothy Mary Keefe: Current status of cancer prevention and treatment in Australia
Editor’s note : Australia faces challenges in the field of cancer prevention and treatment. However, under the challenge, there is also hope. The Australian government is actively taking action to…
-
Dr. Jessica Seidelman: Implementation of a blood culture algorithm in emergency department patients as a diagnostic stewardship intervention
Blood culture is one of the most important tests in the clinical microbiology laboratory. Blood culture is the gold standard for diagnosing bloodstream infection and bacteremia. However, in the United States, blood cultures are still performed even for emergency patients with a low probability of bacteremia, which may result in a large waste of resources.…
-
Multiple HIV Research Achievements by Dr. Yaokai Chen’s Team from Chongqing Public Health Medical Center Was Selected for the 2023 IDWeek
The IDWeek in the United States is one of the largest infectious disease academic conferences globally, often referred to as the “Oscars” of the infectious disease field. Numerous cutting-edge research findings would be shared and discussed at this highly anticipated academic event. During the recent 2023 IDWeek, Dr. Yaokai Chen’s team from Chongqing Public Health…
-
IDWeek Commentary | Dr. Hongzhou Lu: Can ” Online Celebrity Weight Loss Drugs” Also Be Used for HIV-Infected Individuals?
Experiencing weight gain due to medication” is a common concern for many people living with HIV (PLWH). Some antiretroviral therapy (ART) regimens are associated with weight gain and related metabolic complications. In the field of endocrinology, newer antidiabetic medications like glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have been used for weight management and have gained…
-
IDWEEK Live Interview |Dr. Hardy：Leveraging Stewardship to Promote Narrower-spectrum Antibiotic Use for Low-risk AmpC Enterobacterales
AmpC β-lactamases are class C serine β-lactamases that can be produced by a number of Enterobacteriaceae and glucose non-fermenting Gram-negative bacteria. Although AmpC β-lactamases have been associated with the development of third-generation cephalosporin resistance, this risk of AmpC deinhibition is not the same in different enterobacteria. At the recent Infectious Diseases Week 2023 (IDWeek 2023)…
-
2023 China Integrated Oncology Conference Held in Tianjin, Global Oncology Experts Contribute Wisdom to Cancer Prevention and Treatment
The 2023 Chinese Congress of Holistic Integrative Oncology(CCHIO 2023) was held in Tianjin, attracting global oncology experts and scholars to contribute to cancer prevention and treatment. Malignant tumors pose a significant threat to public health, and effective cancer control is crucial for the health of the Chinese population.
Connecting Medical Expertise through Media